---
title: CRO Daily News — September 29, 2026
slug: daily-news-2026-09-29-cro
site: cro
post_kind: news
byline: BioBM
description: September 29 CRO daily: Quotient Sciences Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline — Quotient Sciences' AI formulation…
canonical_url: https://www.cro.directory/posts/daily-news-2026-09-29-cro
published_at: 2026-09-29T23:59:46.072Z
last_updated: 2026-09-30T00:00:55.959Z
---

### Quotient Sciences Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline
- Quotient Sciences will apply machine learning and Bayesian optimization to accelerate oral formulation development for Acesion Pharma's early-stage small-molecule atrial fibrillation candidates.
- The AI-enhanced solution integrates within Quotient's Translational Pharmaceutics® platform to predict formulation performance earlier and shorten development timelines.

**Operational Impact**

Quotient Sciences' AI formulation platform demonstrates a competitive differentiation in translational pharmaceutics that may influence CRO vendor selection for biotech sponsors seeking faster formulation decision-making and earlier clinical readiness.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/quotient-sciences-and-acesion-pharma-launch-ai-formulation-collaboration)*

## References

1. [PharmaSource RSS — Quotient Sciences Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline](https://pharmasource.global/content/news/cdmo-news/quotient-sciences-and-acesion-pharma-launch-ai-formulation-collaboration)

Source: https://www.cro.directory/posts/daily-news-2026-09-29-cro